FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
Quest Diagnostics (NYSE: DGX) reported Q1 EPS of $2.04, $0.18 better than the analyst estimate of $1.86. Revenue for the quarter came in at $2.37 billion versus the consensus estimate of $2.29 billion.
GUIDANCE:
Quest Diagnostics sees FY2024 EPS of $8.72-$8.97, versus the consensus of $8.75.... More

